Psychedelics as Medicines: An Emerging New Paradigm

@article{Nichols2017PsychedelicsAM,
  title={Psychedelics as Medicines: An Emerging New Paradigm},
  author={D. Nichols and M. Johnson and C. Nichols},
  journal={Clinical Pharmacology & Therapeutics},
  year={2017},
  volume={101}
}
Scientific interest in serotonergic psychedelics (e.g., psilocybin and LSD; 5‐HT2A receptor agonists) has dramatically increased within the last decade. Clinical studies administering psychedelics with psychotherapy have shown preliminary evidence of robust efficacy in treating anxiety and depression, as well as addiction to tobacco and alcohol. Moreover, recent research has suggested that these compounds have potential efficacy against inflammatory diseases through novel mechanisms, with… Expand
99 Citations
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.
  • Clinton E Canal
  • Psychology, Medicine
  • Handbook of experimental pharmacology
  • 2018
Psychedelics as anti-inflammatory agents
Psychedelic Drugs in Biomedicine.
Classic psychedelics as therapeutics for psychiatric disorders
Potential Therapeutic Effects of Psilocybin
Psychedelics Promote Structural and Functional Neural Plasticity
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 94 REFERENCES
Psychedelics
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Human hallucinogen research: guidelines for safety
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
...
1
2
3
4
5
...